Folcaps™ Omega-3 | Folcaps Omega-3

05:19 EDT 27th August 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Rx Only

Folcaps™ Omega-3 is a prenatal/postnatal multivitamin/mineral capsule with omega-3 fatty acids.

Each red soft gelatin capsule for oral administration contains:

INACTIVE INGREDIENTS: Gelatin, glycerin, yellow beeswax, silicon dioxide, purified water, soy lecithin, titanium dioxide, FD&C Red #40, ethyl vanillin, and corn oil.

Essential Fatty Acids:
  Omega-3 Fatty Acids The Omega-3 fatty acids are derived from a refined fish oil concentrate and soybean oil. (DHA, EPA, and ALA) 330 mg
    Docohexaenoic Acid (DHA) 260 mg
    Eicosapentaenoic Acid (EPA) 40 mg
    Alpha-linolenic Acid (ALA) 30 mg
  Linoleic Acid 30 mg
  Vitamin C (as calcium ascorbate and calcium threonate) 25 mg
  Vitamin D3 (cholecalciferol) 170 IU
  Vitamin E (dl-alpha-tocopheryl acetate) 30 IU
  Folic Acid, USP 1 mg
  Vitamin B6 (pyridoxine hydrochloride) 25 mg
Calcium Iron (elemental) 150 mg
  Carbonyl iron 20 mg
  Ferrous Asparto Glycinate 7 mg

Folcaps™ Omega-3 is intended to provide improved nutritional status before, during, and after pregnancy, through dietary supplementation of key vitamin/mineral and omega-3 fatty acids.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anti-coagulants and in those known to have inherited or acquired bleeding diathesis.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.

Do not exceed recommended dosage. Folcaps™ Omega-3 should be used with caution in patients with known sensitivity or allergy to fish or soy.

Safety and effectiveness in pediatric patients have not been established.

Clinical studies on this product have not been performed to determine whether elderly subjects respond differently from younger subjects.

In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Usual dosage is one capsule daily, or as prescribed by a physician.

Folcaps™ Omega-3 prenatal/postnatal multivitamin/mineral capsules are red soft gelatin, packaged in bottles of 30 capsules.(NDC: 68308-269-30)

Store at controlled room temperature 15°-30° C (59°-86° F). [See USP controlled room temperature.]



NDC 68308-269-3030 Capsules

Folcaps™Omega 3

DESCRIPTION: Folcaps™ Omega-3 is a prenatal/postnatalmultivitamin/mineral capsule with omega-3 fatty acids.

INACTIVE INGREDIENTS: Gelatin, glycerin, yellow beeswax,silicon dioxide, purified water, soy lecithin, titanium dioxide,FD&C Red #40, ethyl vanillin, and corn oil.

Rx Only


IMAGE folcaps-01.jpg


Midlothian Laboratories

Active Ingredients


Clinical Trials [353 Associated Clinical Trials listed on BioPortfolio]

Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?

To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a spe...

A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules

Comparative bioavailability and pharmacodynamics effects of MAT9001 versus an active omega-3 medication comparator.

Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye

The primary objective of this study is to evaluate the efficacy of REMOGEN® OMEGA in reducing Dry Eye Syndrome (DES) symptoms.

OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer

The purpose of this study is to find an optimal dose of omega-3 that can be given to children who have completed cancer therapy. The future aim is to add omega-3 to conventional cancer tre...

Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis

An increase in intake of omega-3 fatty acids should increase the Omega-3 Index. Current evidence indicates that this may lead to a reduction in risk for sudden cardiac death and atheroscle...

PubMed Articles [191 Associated PubMed Articles listed on BioPortfolio]

High Omega-3 Polyunsaturated Fatty Acids in fat-1 Mice Reduce Inflammatory Pain.

Omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), such as α-linolenic and linoleic acids, are essential fatty acids in mammals, because they cannot be synthesized de novo. However, fat-1 trans...

Effects of dietary omega-3 and -6 supplementations on phospholipid fatty acid composition in mice uterus during window of pre-implantation.

Since fatty acid composition of uterus phospholipids is likely to influence embryo implantation, this study was conducted to investigate the effects of dietary omega-3 and -6 fatty acids on implantati...

The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.

Colorectal cancer is a common malignancy and one of the leading causes of cancer-related deaths. The metabolism of omega fatty acids has been implicated in tumour growth and metastasis.

Omega-3 versus isoflavones in the control of vasomotor symptoms in postmenopausal women.

Determine the efficacy and tolerability of omega-3 fatty acids versus soybean isoflavones in reducing the vasomotor symptoms (VMSs) frequency in postmenopausal women. A randomized, prospective, two-ar...

Long-chain omega-3 fatty acids and cancer: any cause for concern?

Recently, concerns have been raised with regard to the recommended doses of marine long-chain omega-3 polyunsaturated fatty acids (LC-omega-3 PUFAs) especially in relation to cancer risk and treatment...

Quick Search

Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record